Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2010
06/16/2010CN101732342A Oral rehydration salt effervescent tablet and application thereof
06/16/2010CN101732331A Composite of monostalotetrahexosylgangliside and glutamate
06/16/2010CN101732326A Method for preparing vitamin D3 nutrient complex
06/16/2010CN101732321A Medicinal composition containing cefetamet pivoxil hydrochloride and mannitol
06/16/2010CN101732314A Composition of naloxone hydrochloride and polyvinylpyrrolidone and preparation method thereof
06/16/2010CN101732313A Medicine composition of naloxone hydrochloride and polyethylene glycol and preparation method thereof
06/16/2010CN101732312A Huperzine A oral formulation and a preparation method thereof
06/16/2010CN101732309A Insecticidal combination effective against fleas on mammals, particularly cats and dogs
06/16/2010CN101732290A Stable solid formulation of egualen sodium
06/16/2010CN101732286A Voglibose film and preparation method thereof
06/16/2010CN101732284A Nano and micro package of interferon and releasing thereof
06/16/2010CN101732282A Omeprazole enteric capsule and preparation method thereof
06/16/2010CN101732281A Production process of enteric hollow capsule
06/16/2010CN101732280A Oral preparation of novel colonic positioning release medicine
06/16/2010CN101732278A Coating technology of chlorophyll copper sodium tablet film
06/16/2010CN101732277A Stable sitafloxacin medicinal composition and preparation method thereof
06/16/2010CN101732275A Double-layer osmotic pump controlled release tablet of isosorbide mononitrate and preparation method thereof
06/16/2010CN101732272A Loratadine oral disintegrating tablet and preparation method thereof
06/16/2010CN101732271A Dextromethorphan orally disintegrating tablets and preparation method thereof
06/16/2010CN101732270A Dispersing tablet of valsartan and preparation method thereof
06/16/2010CN101732269A Dispersible tablets containing isosorbide mononitrate
06/16/2010CN101732268A Montelukast sodium tablet and preparation method thereof
06/16/2010CN101732264A Cefazedone sodium frozen powder injection and preparation method thereof
06/16/2010CN101732262A Method for preparing freeze-drying particle preparation for injection
06/16/2010CN101732260A Granules of cefetamet pivoxil hydrochloride and preparation method thereof
06/16/2010CN101732258A Nano microsphere preparation used for chemotherapy of tumors and preparation method thereof
06/16/2010CN101732256A Mushroom polysaccharide chitosan nanoparticle and preparation method thereof
06/16/2010CN101732255A Flurbiprofen liposome and preparation method thereof
06/16/2010CN101732252A tropisetron hydrochloride suspension injection
06/16/2010CN101732251A Oxiracetam liposome injection
06/16/2010CN101732250A Preparation method of dihydroartemisinin liquid preparation
06/16/2010CN101732249A Indometacin injection for livestock and preparation method thereof
06/16/2010CN101732248A Metoprolol tartrate injection and preparation method thereof
06/16/2010CN101732247A Edaravone-containing injection
06/16/2010CN101732246A Moxifloxacin aqueous solution type injection
06/16/2010CN101732245A Two-phase isophane zinc recombinant human insulin injection and preparation method thereof
06/16/2010CN101732241A Cream of butenafine hydrochloride and preparation method thereof
06/16/2010CN101732240A Externally used ointment for relieving pain and activating blood circulation
06/16/2010CN101732238A Mitomycin c ophthalmic gel
06/16/2010CN101732237A Baicalin thermosensitive gelatin and preparation method and use thereof
06/16/2010CN101732236A Solid medicine preparation for preventing agglomeration and discoloration and preparation method thereof
06/16/2010CN101732235A Solid dispersion of tamoxifen citrate, method for preparing same and application thereof
06/16/2010CN101732234A Method for preparing block polymer micelle freeze-drying preparation carrying docetaxel
06/16/2010CN101732233A Method for preparing solid dispersion
06/16/2010CN101732230A Sustained-release preparation
06/16/2010CN101732229A Borneol inclusion compound and preparation method thereof
06/16/2010CN101322845B Erianin inclusion compound
06/16/2010CN101314046B Cyclodextrin inclusion method for hair orchid native
06/16/2010CN101283965B Preparation containing bendopa methyl ester and preparation method thereof
06/16/2010CN101269220B Rapamycin eye-in implantation type medicine release system with bletilla striata glue as carrier
06/16/2010CN101269051B Rumen bypass becholine microcapsule and preparation technique
06/16/2010CN101249071B Preparation of 2-methoxyl group estradiol vena nano emulsions
06/16/2010CN101235155B Method for preparing polylactic acid, polyvinyl alcohol and brazilwood mixed nano or micron fibrous membrane
06/16/2010CN101229375B Medicine compounds containing isosorbide mononitrate for treating high blood pressure
06/16/2010CN101225146B Chitosan-ketoprofen grafts and preparation method thereof
06/16/2010CN101214223B Closantel or its sodium salt long-acting sustained-release injection and preparation thereof
06/16/2010CN101204371B Vitamin C injection and preparation method thereof
06/16/2010CN101167725B Nimodipine long circulating vesicle and its freezing-dried preparation
06/16/2010CN101134784B Agarose and hyaluronic acid grafts and preparation method and uses thereof
06/16/2010CN101052373B Suction tablet containing octenidine for oral and pharyngeal cavity inflammation
06/16/2010CN101007868B Preparation method of biodegradable nano micelle controlled release formulation
06/16/2010CN101001616B Polymeric adhesive matrix with salified carboxylic groups for transdermal use
06/15/2010US7737260 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic
06/15/2010US7737258 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/15/2010US7737251 conjugates comprising blood proteins covalently coupled to a gastrointestinal tissue growth promoter derivatives, having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders
06/15/2010US7737240 for cells, proteins, DNA or other molecules encapsulation; carragenan, chitosan, hyaluronic acid, cellulose or alginate; with thiophene, aniline or pyrrole polymerizable moiety grafted on
06/15/2010US7737226 Acetylene group-containing poly(alkylene oxide, oxyethylated polyol or olefinic alcohol)
06/15/2010US7737181 Topical adapalene for acne and other inflammatory or proliferative skin disorders
06/15/2010US7737130 Pharmaceutical compositions for topical use in treatment of skin or mucous injuries
06/15/2010US7737108 Enhanced transport using membrane disruptive agents
06/15/2010US7736885 Method for production of arachidonic acid
06/15/2010US7736679 comprises curcumin and an essential oil of turmeric
06/15/2010US7736674 Controlled release compositions for interferon based on PEGT/PBT block copolymers
06/15/2010US7736670 The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the
06/15/2010US7736667 Release rate constant over time for several hours within the early part of the release profile, confining the release to the upper GI tract; shell remains intact during entire period of drug release
06/15/2010US7736666 Consists of naproxen, a butyl spacer and a nitrogen oxide (NO)-releasing nitrate group, linked together into a single molecule; useful as antiinflammatory agent and an analgesic
06/15/2010US7736659 Clostridial toxin derivatives and methods for treating pain
06/15/2010US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic
06/15/2010US7736653 Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier
06/15/2010US7736644 Monoclonal antibody for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy
06/15/2010US7736635 3-Maleimidyl-N-(2-{[3-maleimidyl-propionyl]-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-amino}-ethyl)-N-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-propionamide linked to 2 polyoxyethyelne glycol residue and two antibodies or fragments; conjugate; biodegradable
06/15/2010US7736625 Light stabilized in vivo stain composition and method of manufacture
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010US7735485 Dry powder inhalation system for transpulmonary administration
06/15/2010CA2687017A1 Method for manufacturing edible film
06/15/2010CA2481868C Preparation of powder agglomerates
06/15/2010CA2407072C Taste masking coating composition
06/15/2010CA2398668C Delivery systems using preformed biodegradable polymer compositions and methods
06/15/2010CA2366833C Hemoglobin-antioxidant conjugates
06/15/2010CA2328922C Terminally-branched polymeric linkers and polymeric conjugates containing the same
06/15/2010CA2250080C Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
06/10/2010WO2010065730A2 Pharmaceutical suspension
06/10/2010WO2010065329A2 Nanoparticles for cancer treatment
06/10/2010WO2010064636A1 Ophthalmic composition
06/10/2010WO2010064522A1 Inhalant comprising modified superoxide dismutase
06/10/2010WO2010064441A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
06/10/2010WO2010064258A2 Pharmaceutical formulations of interferon conjugates
06/10/2010WO2010064207A2 Selective anticancer chimeric peptide
06/10/2010WO2010063998A2 Antibiotic nanomaterial
06/10/2010WO2010063988A1 Germicidal topical compositions
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 1712